Iwasaki Y, Okamura T, Ozaki A, Todoroki T, Takase Y, Ohara K, Nishimura A, Otsu H
Surg Gynecol Obstet. 1986 May;162(5):457-64.
During the period of November 1976 through October 1984, we have treated 46 patients with carcinoma at the confluence of the major hepatic ducts. Curative resection of the tumor (where no carcinoma cells at the margin of the resected portion were found macroscopically and microscopially), was performed upon ten patients, palliative resections were done in 11, palliative resection and intraoperative radiotherapy (IOR) in ten, bile duct drainage and IOR in three, and percutaneous transhepatic cholangiodrainage in 12. Among the ten patients who underwent curative operation, five are living six to 104 months after operation while the remaining five died four to 72 months postoperatively. Of the 11 patients who underwent palliative resection, five are alive two to 22 months after operation and six died between four and 20 months after operation. For the ten patients with carcinoma in the advanced stages, palliative resection with IOR was performed. Eight patients died 20 days to 16 months after operation while two patients are alive 13 and 14 months after the procedure. Of the three patients who underwent drainage of the bile duct and IOR, two died three months after operation and one patient survived 34 months. Twelve patients underwent drainage of the bile duct only and all died after 13 months. To perform a curative operation for carcinoma located at the confluence of major hepatic ducts, it is necessary to resect the right or left lobe, including the caudate lobe, in many instances. For the patients with carcinoma in the advanced stages, the possibility of long term survival period after operation exists through the use of the combined techniques of IOR and palliative resection of the tumor.
在1976年11月至1984年10月期间,我们共治疗了46例肝门部胆管癌患者。对10例患者进行了肿瘤根治性切除(切除边缘在肉眼和显微镜下均未发现癌细胞),11例行姑息性切除,10例行姑息性切除加术中放疗(IOR),3例行胆管引流加术中放疗,12例行经皮经肝胆管引流。在接受根治性手术的10例患者中,5例术后存活6至104个月,其余5例术后4至72个月死亡。在接受姑息性切除的11例患者中,5例术后存活2至22个月,6例术后4至20个月死亡。对于10例晚期癌症患者,进行了姑息性切除加术中放疗。8例患者术后20天至16个月死亡,2例患者术后13和14个月存活。在接受胆管引流加术中放疗的3例患者中,2例术后3个月死亡,1例患者存活34个月。12例患者仅接受了胆管引流,均在13个月后死亡。对于位于肝门部的癌症进行根治性手术,在许多情况下需要切除右叶或左叶,包括尾状叶。对于晚期癌症患者,通过术中放疗和肿瘤姑息性切除的联合技术,术后存在长期存活的可能性。